This document contains a series of case reports describing the use of SILVERCEL® NON-ADHERENT (Systagenix) in patients with a range of wound types. All patients were treated for a minimum of four weeks and the decision to continue with SILVERCEL® NON-ADHERENT was based on continual assessment. A formal assessment was performed weekly, although in some cases dressing changes were carried out more frequently.
Supported by KCI – An Acelity Company
